ESR1 and breast carcinoma: Also, in breast cancer tissues, STopover was able to capture the distinct immune phenotypes present in ER + and TNBC tumors, with ER + tissues exhibiting immune-excluded patterns and TNBC showing immune-inflamed patterns (Fig. 7).